These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9227410)

  • 1. Eicosanoid production from porcine neutrophils and platelets: differential production with various agonists.
    Stahl GL; Morse DS; Martin SL
    Am J Physiol; 1997 Jun; 272(6 Pt 1):C1821-8. PubMed ID: 9227410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C5a-induced myocardial ischemia: role for CD18-dependent PMN localization and PMN-platelet interactions.
    Fletcher MP; Stahl GL; Longhurst JC
    Am J Physiol; 1993 Nov; 265(5 Pt 2):H1750-61. PubMed ID: 7902015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcellular metabolism of arachidonic acid: increased platelet thromboxane generation in the presence of activated polymorphonuclear leukocytes.
    Maugeri N; Evangelista V; Piccardoni P; Dell'Elba G; Celardo A; de Gaetano G; Cerletti C
    Blood; 1992 Jul; 80(2):447-51. PubMed ID: 1627802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.
    Ferrer-Lopez P; Renesto P; Schattner M; Bassot S; Laurent P; Chignard M
    Am J Physiol; 1990 Jun; 258(6 Pt 1):C1100-7. PubMed ID: 2360620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of platelet 12-HETE production in the presence of polymorphonuclear leukocytes during calcium ionophore stimulation.
    McCulloch RK; Croft KD; Vandongen R
    Biochim Biophys Acta; 1992 Jan; 1133(2):142-6. PubMed ID: 1731956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of co-incubation and cell number of platelets and polymorphonuclear leukocytes in cellular inhibition and activation phenomena.
    Hernández R; Alemany M; Bozzo J; Ordinas A; Bastida E
    Thromb Res; 1994 May; 74(3):255-63. PubMed ID: 8042192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoxin A augments release of thromboxane from human polymorphonuclear leukocyte suspensions.
    Conti P; Reale M; Cancelli A; Angeletti PU
    FEBS Lett; 1987 Dec; 225(1-2):103-8. PubMed ID: 3121389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoxin generation by permeabilized human platelets.
    Romano M; Serhan CN
    Biochemistry; 1992 Sep; 31(35):8269-77. PubMed ID: 1381961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells.
    Papayianni A; Serhan CN; Brady HR
    J Immunol; 1996 Mar; 156(6):2264-72. PubMed ID: 8690917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane B2 and leukotriene C4 cooperative synthesis.
    Maugeri N; Evangelista V; Celardo A; Dell'Elba G; Martelli N; Piccardoni P; de Gaetano G; Cerletti C
    Thromb Haemost; 1994 Sep; 72(3):450-6. PubMed ID: 7531878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils.
    Fiore S; Romano M; Serhan CN
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():93-6. PubMed ID: 1825593
    [No Abstract]   [Full Text] [Related]  

  • 12. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
    O'Flaherty JT
    J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human neutrophil and endothelial cell ligand-operated extracellular acidification rate by microphysiometry: impact of reoxygenation.
    Gronert K; Colgan SP; Serhan CN
    J Pharmacol Exp Ther; 1998 Apr; 285(1):252-61. PubMed ID: 9536019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of platelet-activating factor (PAF) in superoxide production by human polymorphonuclear leukocytes.
    Takahashi S; Yoshikawa T; Naito Y; Tanigawa T; Yoshida N; Kondo M
    Lipids; 1991 Dec; 26(12):1227-30. PubMed ID: 1668119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy.
    Brezinski DA; Nesto RW; Serhan CN
    Circulation; 1992 Jul; 86(1):56-63. PubMed ID: 1617790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in platelet-polymorphonuclear leukocyte interaction.
    de Gaetano G; Cerletti C; Evangelista V
    Haemostasis; 1999 Sep; 29(1):41-9. PubMed ID: 10494033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation.
    Camussi G; Tetta C; Bussolino F; Caligaris Cappio F; Coda R; Masera C; Segoloni G
    Int Arch Allergy Appl Immunol; 1981; 64(1):25-41. PubMed ID: 7450901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases.
    Evangelista V; Rajtar G; de Gaetano G; White JG; Cerletti C
    Blood; 1991 Jun; 77(11):2379-88. PubMed ID: 1645603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming.
    Bauldry SA; McCall CE; Cousart SL; Bass DA
    J Immunol; 1991 Feb; 146(4):1277-85. PubMed ID: 1846897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of platelet activating factor on release of thromboxane B2 from human granulocytes and platelets].
    Imai T; Horikoshi S; Kurokawa M; Idaira K; Mita S; Adachi M; Okamoto M
    Arerugi; 1994 Jul; 43(7):809-14. PubMed ID: 7980021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.